During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study.

Journal of Psychopharmacology
Derek G MooreLynn T Singer

Abstract

While recreational drug use in UK women is prevalent, to date there is little prospective data on patterns of drug use in recreational drug-using women immediately before and during pregnancy. A total of 121 participants from a wide range of backgrounds were recruited to take part in the longitudinal Development and Infancy Study (DAISY) study of prenatal drug use and outcomes. Eighty-six of the women were interviewed prospectively while pregnant and/or soon after their infant was born. Participants reported on use immediately before and during pregnancy and on use over their lifetime. Levels of lifetime drug use of the women recruited were high, with women reporting having used at least four different illegal drugs over their lifetime. Most users of cocaine, 3,4-methylenedioxy-N-methylamphetamine (MDMA) and other stimulants stopped using these by the second trimester and levels of use were low. However, in pregnancy, 64% of the sample continued to use alcohol, 46% tobacco and 48% cannabis. While the level of alcohol use reduced substantially, average tobacco and cannabis levels tended to be sustained at pre-pregnancy levels even into the third trimester (50 cigarettes and/or 11 joints per week). In sum, while the use of 'party...Continue Reading

References

May 24, 2000·Drug and Alcohol Dependence·A C ParrottJ J Turner
Aug 25, 2000·Psychopharmacology·J Rodgers
Feb 15, 2002·BJOG : an International Journal of Obstetrics and Gynaecology·David M FergussonUNKNOWN ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood
Apr 19, 2002·JAMA : the Journal of the American Medical Association·Lynn T SingerRobert Kliegman
May 27, 2004·JAMA : the Journal of the American Medical Association·Lynn T SingerH Lester Kirchner
Jun 15, 2004·Drug and Alcohol Dependence·Lynn T SingerSonia Minnes
Aug 13, 2005·Neuroscience and Biobehavioral Reviews·Anja C Huizink, Eduard J H Mulder
Mar 3, 2006·Journal of Psychopharmacology·C T J LamersJ G Ramaekers
May 10, 2006·Journal of Psychoactive Drugs·George S Yacoubian, Eric D Wish
Dec 19, 2006·Neurotoxicology and Teratology·Brian J Piper
Jul 11, 2007·Psychopharmacology·Peter G RendellAnne Tolan
Mar 12, 2008·Behavioural Pharmacology·Matthew R SkeltonCharles V Vorhees
Sep 10, 2008·Drug and Alcohol Dependence·Jennifer R HavensWendy F Hansen

❮ Previous
Next ❯

Citations

Apr 1, 2013·Journal of Developmental Origins of Health and Disease·M E AltonA L Kozyrskyj
May 31, 2012·Journal of Health Care for the Poor and Underserved·Kisha B HoldenStephanie Hall
Aug 22, 2012·Pediatrics·Lynn T SingerAndrew C Parrott
Sep 24, 2013·PeerJ·Valeria FeinshteinGershon Holcberg
Jan 25, 2014·Journal of Perinatology : Official Journal of the California Perinatal Association·S C JaquesJ L Oei
Nov 25, 2014·Toxicology Reports·Michael T WilliamsRussell W Brown
Jan 26, 2016·Neurotoxicology and Teratology·Lynn T SingerAndrew C Parrott
Apr 22, 2015·Archives of Women's Mental Health·Katrina MarkMishka Terplan
May 15, 2015·Archives of Women's Mental Health·Janet E ShuAlexandre Faisal-Cury
Feb 9, 2012·Primary Care·Erin Kate Dooley, Robert L Ringler
May 20, 2015·American Journal of Obstetrics and Gynecology·Torri D Metz, Elaine H Stickrath
Sep 29, 2011·Journal of Intellectual Disability Research : JIDR·D G Moore, R George
Sep 21, 2015·Current Psychiatry Reports·Ariadna Forray, Dawn Foster
May 12, 2015·Neuroscience and Biobehavioral Reviews·Alejandro Higuera-MatasEmilio Ambrosio
Mar 24, 2012·Journal of Ethnopharmacology·Kamarudin Ahmad, Zoriah Aziz
Mar 17, 2015·Drug and Alcohol Dependence·Ariadna ForrayKimberly A Yonkers
Jul 8, 2011·The International Journal of Neuropsychopharmacology·Matthew R SkeltonCharles V Vorhees
May 13, 2017·Journal of Midwifery & Women's Health·Megan E Foeller, Deirdre J Lyell
Jan 27, 2018·The Journal of Perinatal & Neonatal Nursing·Cynthia Krening, Keri Hanson
Jan 18, 2018·Fundamental & Clinical Pharmacology·Liselotte PochardUNKNOWN French Addictovigilance Network
Nov 23, 2017·Archives of Disease in Childhood. Fetal and Neonatal Edition·Eloise Müller-SchulteAnja Harder
Jan 10, 2012·Anesthesiology·Ansgar M BrambrinkJohn W Olney
May 19, 2020·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Emily LeeRashmi Rao
Aug 5, 2015·Obstetrics and Gynecology·UNKNOWN American College of Obstetricians and Gynecologists Committee on Obstetric Practice
Jun 22, 2012·Acta Psychiatrica Scandinavica·M V Seeman
Jul 29, 2015·Human Psychopharmacology·Lynn T SingerAndrew C Parrott
Jul 26, 2019·Obstetrical & Gynecological Survey·Rebecca ThompsonJamie Lo
Mar 10, 2017·Obstetrics and Gynecology·Jennifer VillavicencioNancy C Chescheir
Dec 15, 2020·BMC Pregnancy and Childbirth·Camilla A MichalskiJulia A Knight
May 4, 2020·Journal of Substance Abuse Treatment·Kimberly A YonkersSteve Martino
Jul 29, 2021·Adversity and Resilience Science·Lynn T SingerJulie Kable
Aug 28, 2021·International Journal of Molecular Sciences·Annia A Martínez-PeñaSandeep Raha
Sep 12, 2021·American Journal of Clinical Pathology·Joshua J H HunsakerJonathan R Genzen
Aug 29, 2018·Pediatrics·Sheryl A RyanUNKNOWN SECTION ON BREASTFEEDING
Mar 6, 2012·Neurotoxicology and Teratology·Lynn T SingerAndrew C Parrott

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.